ALK and neuroblastoma: The reports from Javanmardi et al. and Borenäs et al. consider 2p-gain and the ALKAL2 ligand, highlighting the potential importance of addressing the activation status of ALK at the protein level in neuroblastoma [46,66] (Figure 5).